Stock broker and growing crypto platform eToro has made its move onto Wall Street, setting its initial public offering price at $52 per share.
The decision signals the company’s readiness to test investor appetite for a new listing in a market still finding its footing after a period of volatility.
Headquartered in Israel, the firm raised nearly $310 million by selling almost 6 million shares, giving the company an implied valuation of roughly $4.2 billion.
That price sits above the initial target range of $46 to $50 per share.
In addition to the company’s offering, existing investors are selling about 6 million additional shares, creating a meaningful public float.
The path to this point has been paved with cautious optimism.
The IPO market had shown signs of revival earlier this year, a trend some attributed in part to political developments in January, when President Donald Trump returned to the White House. That event raised hopes among some market participants that a long drought—driven by rising interest rates and persistent inflation concerns—might ease.
Indeed, the successful March debut of CoreWeave offered a glimmer of encouragement to other ambitious companies eyeing public markets, including eToro, online lending giant Klarna and ticket reseller StubHub.
But the nascent recovery has encountered obstacles.
“Tariff uncertainty paused those plans for a time,” the original report noted, reflecting a period of market unease.
As a result, eToro — which filed for an IPO in March — along with Klarna and StubHub, delayed immediate listing plans as markets wrestled with the implications of changing trade policies.
A gauge of risk appetite? eToro’s debut and market sentiment
Now preparing to make its Nasdaq debut under the ticker ETOR, eToro’s performance could serve as an important litmus test for broader public-market risk tolerance.
The IPO landscape shows renewed activity: digital physical-therapy provider Hinge Health has launched its roadshow, disclosing in a filing that it aims to raise up to $437 million.
Also this week, fintech innovator Chime filed its prospectus with the SEC, signaling its own public-market ambitions.
Earlier in April, trading app Webull announced plans to go public through a merger with a special purpose acquisition company (SPAC), another sign of renewed IPO activity.
Crypto ambitions driving growth and investor interest
Founded in 2007 by brothers Yoni and Ronen Assia along with David Ring, eToro competes in a crowded field, challenging established players such as Robinhood.
Its revenue model relies on trading-related fees—including spreads on buy and sell orders—as well as non-trading services like withdrawals and currency conversions.
The company’s financial trajectory has been notable: net revenue surged nearly thirteen-fold last year to $192.4 million, up from $15.3 million the year before.
A key driver of that growth has been its expanding crypto business.
Revenue from crypto assets more than tripled to exceed $12 million in 2024, and crypto-related activity accounted for a quarter of its net trading contributions last year, a sharp jump from 10% the prior year.
This is not eToro’s first venture toward a public offering.
In 2022, the company abandoned plans to go public via a SPAC merger amid a deep downturn in equity markets, according to its filings.
That earlier deal would have valued eToro at well over $10 billion.
Despite the earlier setback, CEO Yoni Assia has remained committed to a public listing. He told CNBC last year that eToro was still targeting a market debut while “assessing the right opportunity” and strengthening relationships with exchanges, including Nasdaq.
“We are certainly watching the public markets,” Assia said at the time. “I do see us eventually becoming a public company.”
Adding confidence to the current offering, eToro disclosed in its prospectus that investment giant BlackRock had “expressed interest in purchasing $100 million of shares at the IPO price.”
The company detailed plans to sell 5 million shares in the offering, with existing investors and executives slated to sell an additional 5 million shares.
The underwriting syndicate for this significant financial move includes industry heavyweights Goldman Sachs, Jefferies and UBS.